SEC Form 4 · accession 0001312326-18-000002
Lexaria Bioscience Corp. · LXRP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nicholas W Baxter
Director
Period of report
Dec 16, 2015
Accepted (ET)
Jun 1, 2018 · 3:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001348362
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options | $1.53 | May 31, 2018 | P | 50,000 | A | May 31, 2023 | May 31, 2023 | Lexaria Common Shares | 50,000 | 160,000 | D |
| Options | $0.10 | holding | — | — | — | Dec 23, 2019 | Dec 23, 2019 | Lexaria Common Shares | 110,000 | 110,000 | D |